Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study
about
Therapeutic Use of Native and Recombinant EnterovirusesMicroRNA-Detargeted Mengovirus for Oncolytic VirotherapyCombining Oncolytic Virotherapy with p53 Tumor Suppressor Gene TherapyOncolytic virotherapy including Rigvir and standard therapies in malignant melanoma.Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus.Bioselection of coxsackievirus B6 strain variants with altered tropism to human cancer cell lines.Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports.Novel treatment opportunities for sulfur mustard-related cancers: genetic and epigenetic perspectives.Review: Oncolytic virotherapy, updates and future directions.Traveling treatment: medical tourism in the emerging era of potentially transmissible therapeutics.Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro.Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report.Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery
P2860
Q26767082-214F7735-5336-4C83-84F9-73D1EF1D7349Q28601803-9C31D825-248A-45E6-819A-5B8F9942807FQ33633277-9287D2DE-7081-4D17-AB09-51167A3CBE56Q37641495-ED39DCAE-7798-426D-AD4C-7A78704479B8Q37641644-1FFACACD-3FC5-48EF-9E1F-FDE128C7AA47Q38676507-3DE137B3-5FC1-406F-A133-183A8928A95AQ38695916-559AB286-B83D-4496-8623-6293ACCF409BQ45324769-DBD8A2E8-7E5B-47A0-8FD2-5E9ACC1D9E8FQ45334383-41042258-F218-415C-87CD-D96BEDC75D46Q45873027-50A965E1-8E2A-4D35-AA14-F527A567B6A8Q47160989-AF904944-0023-40DA-B4CE-5252657898D5Q49860130-41E7CD56-2A12-4D15-90A5-45BAAE1CC09CQ51734249-40723DC7-00CE-4701-99F0-3FFF3EBD5598Q54256421-C731AA7F-1D8E-446A-A7C2-4288C582F49EQ57132503-2B67D5C5-C2AE-41D1-8118-999B9DB6D375
P2860
Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Adapted ECHO-7 virus Rigvir im ...... umour in a retrospective study
@ast
Adapted ECHO-7 virus Rigvir im ...... umour in a retrospective study
@en
type
label
Adapted ECHO-7 virus Rigvir im ...... umour in a retrospective study
@ast
Adapted ECHO-7 virus Rigvir im ...... umour in a retrospective study
@en
prefLabel
Adapted ECHO-7 virus Rigvir im ...... umour in a retrospective study
@ast
Adapted ECHO-7 virus Rigvir im ...... umour in a retrospective study
@en
P2093
P2860
P1433
P1476
Adapted ECHO-7 virus Rigvir im ...... umour in a retrospective study
@en
P2093
Aina Muceniece
Björn Jonsson
Dite Venskus
Guna Proboka
Ieva Strēle
Jurgis Auziņš
Pēteris Alberts
Simona Doniņa
P2860
P304
P356
10.1097/CMR.0000000000000180
P407
P577
2015-07-15T00:00:00Z